Froedtert Hospital
Milwaukee, Wisconsin, 53226, United States
NCT Number: NCT02340715
The purpose of this study is to determine if it would be helpful to use advanced MRI imaging techniques to take additional views of the tumor target for radiation treatment planning or treatment follow-up MRI.
Looking for future studies?
Notify Me18 year–89 year
All sexes
Observational
Milwaukee, Wisconsin, 53226, United States
The results of this research project will be used to establish a standard MRI protocol specific to each tumor or disease site. An MRI protocol is a list of MR image types that are acquired for each disease site. These images are used to generate the patient's treatment plan.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: up to 4 weeks from imaging
We tested these Advanced MR protocols to evaluate which ones would best visualize the target region. This helped us determine the optimum MR SIM protocols for different sites that became clinical standard.
Medical College of Wisconsin
Other
Investigation on the Utility of Advanced MRI Imaging Methods for Radiation Therapy Treatment Planning
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05708950
Adnexal Diseases, Breast Cancer
Santa Monica, California, United States
View Trial DetailsNCT05131815
Astrocytoma, Behavior
Los Angeles, California, United States
View Trial DetailsNCT04604158
Anxiety, Anxiety Disorders
Los Angeles, California, United States
View Trial DetailsNCT00477919
Adenocarcinoma, Adenoma
Basel, Switzerland
View Trial Details